SCA
PHAS

Snowden Capital Advisors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Snowden Capital Advisors’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$10K Hold
2022
Q2 		$36K Buy
2022
Q1 		$68K Buy
2021
Q4 		$75K Buy
2021
Q3 		$65.3K Buy
2021
Q2 		$74.4K Hold
2021
Q1 		$69.2K Buy